FIGO staging of endometrial cancer: 2023.
Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N; Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee.
Int J Gynaecol Obstet. 2023 Aug;162(2):383-394. doi: 10.1002/ijgo.14923. Epub 2023 Jun 20.
Tumor-like cystic endosalpingiosis in the myometrium: a case report and a review of the literature.
Yığıt S, Dere Y, Yetımalar H, Etıt D.
Turk Patoloji Derg. 2014;30(2):145-8. doi: 10.5146/tjpath.2013.01176.
Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
Mowers EL, Skinner B, McLean K, Reynolds RK.
J Minim Invasive Gynecol. 2015 May-Jun;22(4):601-6. doi: 10.1016/j.jmig.2015.01.007. Epub 2015 Jan 14.
Imaging in endometrial cancer.
Epstein E, Blomqvist L.
Best Pract Res Clin Obstet Gynaecol. 2014 Jul;28(5):721-39. doi: 10.1016/j.bpobgyn.2014.04.007. Epub 2014 Apr 30.
Carcinoma of the endometrium.
Southcott BM.
Drugs. 2001;61(10):1395-405. doi: 10.2165/00003495-200161100-00003.
Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update.
Makker A, Goel MM.
Endocr Relat Cancer. 2016 Feb;23(2):R85-R111. doi: 10.1530/ERC-15-0218. Epub 2015 Nov 4.
A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma.
Lewis TD, Malik M, Britten J, San Pablo AM, Catherino WH.
Biomed Res Int. 2018 Jan 28;2018:2414609. doi: 10.1155/2018/2414609. eCollection 2018.
Secondary Tumors of the Gynecologic Tract: A Clinicopathologic Analysis.
Karpathiou G, Chauleur C, Hathroubi S, Peoc'h M.
Int J Gynecol Pathol. 2019 Jul;38(4):363-370. doi: 10.1097/PGP.0000000000000516.
Clinicopathological features and molecular genetic changes in 17 cases of uterine tumor resembling ovarian sex cord tumor.
Qijun C, Wei W, Cheng W, Dongni L.
Hum Pathol. 2024 Jan;143:33-41. doi: 10.1016/j.humpath.2023.11.007. Epub 2023 Nov 23.
Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).
Mangieri CW, Valenzuela CD, Solsky IB, Erali RA, Votanopoulos KI, Shen P, Levine EA.
J Surg Oncol. 2023 Mar;127(3):450-456. doi: 10.1002/jso.27122. Epub 2022 Oct 26.
